BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chatfield KC, Sparagna GC, Chau S, Phillips EK, Ambardekar AV, Aftab M, Mitchell MB, Sucharov CC, Miyamoto SD, Stauffer BL. Elamipretide Improves Mitochondrial Function in the Failing Human Heart. JACC Basic Transl Sci 2019;4:147-57. [PMID: 31061916 DOI: 10.1016/j.jacbts.2018.12.005] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Manolis AS, Manolis AA, Manolis TA, Apostolaki NE, Apostolopoulos EJ, Melita H, Katsiki N. Mitochondrial dysfunction in cardiovascular disease: Current status of translational research/clinical and therapeutic implications. Med Res Rev 2021;41:275-313. [PMID: 32959403 DOI: 10.1002/med.21732] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
2 de Souza BTL, Klosowski EM, Mito MS, Constantin RP, Mantovanelli GC, Mewes JM, Bizerra PFV, da Silva FSI, Menezes PVMDC, Gilglioni EH, Utsunomiya KS, Marchiosi R, Dos Santos WD, Ferrarese-Filho O, Caetano W, de Souza Pereira PC, Gonçalves RS, Constantin J, Ishii-Iwamoto EL, Constantin RP. The photosensitiser azure A disrupts mitochondrial bioenergetics through intrinsic and photodynamic effects. Toxicology 2021;455:152766. [PMID: 33775737 DOI: 10.1016/j.tox.2021.152766] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Wu C, Zhang Z, Zhang W, Liu X. Mitochondrial dysfunction and mitochondrial therapies in heart failure. Pharmacol Res 2021;175:106038. [PMID: 34929300 DOI: 10.1016/j.phrs.2021.106038] [Reference Citation Analysis]
4 Ajmal M, Ajmal A, Huang L, Zeng L. The Potential Therapeutic Role of Celastrol in Patients With Heart Failure With Preserved Ejection Fraction. Front Cardiovasc Med 2021;8:725602. [PMID: 34490381 DOI: 10.3389/fcvm.2021.725602] [Reference Citation Analysis]
5 Cortés-Rojo C, Vargas-Vargas MA, Olmos-Orizaba BE, Rodríguez-Orozco AR, Calderón-Cortés E. Interplay between NADH oxidation by complex I, glutathione redox state and sirtuin-3, and its role in the development of insulin resistance. Biochim Biophys Acta Mol Basis Dis 2020;1866:165801. [PMID: 32305451 DOI: 10.1016/j.bbadis.2020.165801] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
6 Hammer Y, Blin M, Goldstein DR. Failing mitochondria and Coronary allograft vasculopathy. The Journal of Heart and Lung Transplantation 2022. [DOI: 10.1016/j.healun.2022.02.014] [Reference Citation Analysis]
7 Johnson J, Mercado-Ayón E, Clark E, Lynch D, Lin H. Drp1-dependent peptide reverse mitochondrial fragmentation, a homeostatic response in Friedreich ataxia. Pharmacol Res Perspect 2021;9:e00755. [PMID: 33951329 DOI: 10.1002/prp2.755] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
8 Zhang X, Wada S, Zhang Y, Chen D, Deng XH, Rodeo SA. Assessment of Mitochondrial Dysfunction in a Murine Model of Supraspinatus Tendinopathy. J Bone Joint Surg Am 2021;103:174-83. [PMID: 32941310 DOI: 10.2106/JBJS.20.00385] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Machiraju P, Wang X, Sabouny R, Huang J, Zhao T, Iqbal F, King M, Prasher D, Lodha A, Jimenez-Tellez N, Ravandi A, Argiropoulos B, Sinasac D, Khan A, Shutt TE, Greenway SC. SS-31 Peptide Reverses the Mitochondrial Fragmentation Present in Fibroblasts From Patients With DCMA, a Mitochondrial Cardiomyopathy. Front Cardiovasc Med 2019;6:167. [PMID: 31803760 DOI: 10.3389/fcvm.2019.00167] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
10 Dias Amoedo N, Dard L, Sarlak S, Mahfouf W, Blanchard W, Rousseau B, Izotte J, Claverol S, Lacombe D, Rezvani HR, Pierri CL, Rossignol R. Targeting Human Lung Adenocarcinoma with a Suppressor of Mitochondrial Superoxide Production. Antioxid Redox Signal 2020;33:883-902. [PMID: 32475148 DOI: 10.1089/ars.2019.7892] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
11 Zuccarelli M, Vella-Szijj J, Serracino-Inglott A, Borg JJ. Treatment of Leber's hereditary optic neuropathy: An overview of recent developments. Eur J Ophthalmol 2020;30:1220-7. [PMID: 32552047 DOI: 10.1177/1120672120936592] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Russell OM, Gorman GS, Lightowlers RN, Turnbull DM. Mitochondrial Diseases: Hope for the Future. Cell 2020;181:168-88. [PMID: 32220313 DOI: 10.1016/j.cell.2020.02.051] [Cited by in Crossref: 57] [Cited by in F6Publishing: 52] [Article Influence: 28.5] [Reference Citation Analysis]
13 Sequiera GL, Srivastava A, Sareen N, Yan W, Alagarsamy KN, Verma E, Aghanoori MR, Aliani M, Kumar A, Fernyhough P, Rockman-Greenberg C, Dhingra S. Development of iPSC-based clinical trial selection platform for patients with ultrarare diseases. Sci Adv 2022;8:eabl4370. [PMID: 35394834 DOI: 10.1126/sciadv.abl4370] [Reference Citation Analysis]
14 Forini F, Canale P, Nicolini G, Iervasi G. Mitochondria-Targeted Drug Delivery in Cardiovascular Disease: A Long Road to Nano-Cardio Medicine. Pharmaceutics 2020;12:E1122. [PMID: 33233847 DOI: 10.3390/pharmaceutics12111122] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
15 Paradies G, Paradies V, Ruggiero FM, Petrosillo G. Role of Cardiolipin in Mitochondrial Function and Dynamics in Health and Disease: Molecular and Pharmacological Aspects. Cells 2019;8:E728. [PMID: 31315173 DOI: 10.3390/cells8070728] [Cited by in Crossref: 72] [Cited by in F6Publishing: 62] [Article Influence: 24.0] [Reference Citation Analysis]
16 Jiang Q, Yin J, Chen J, Ma X, Wu M, Liu G, Yao K, Tan B, Yin Y. Mitochondria-Targeted Antioxidants: A Step towards Disease Treatment. Oxid Med Cell Longev 2020;2020:8837893. [PMID: 33354280 DOI: 10.1155/2020/8837893] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
17 Tomczyk MM, Dolinsky VW. The Cardiac Lipidome in Models of Cardiovascular Disease. Metabolites 2020;10:E254. [PMID: 32560541 DOI: 10.3390/metabo10060254] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
18 Chavez JD, Tang X, Campbell MD, Reyes G, Kramer PA, Stuppard R, Keller A, Zhang H, Rabinovitch PS, Marcinek DJ, Bruce JE. Mitochondrial protein interaction landscape of SS-31. Proc Natl Acad Sci U S A 2020;117:15363-73. [PMID: 32554501 DOI: 10.1073/pnas.2002250117] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 12.0] [Reference Citation Analysis]
19 Sabbah HN. Barth syndrome cardiomyopathy: targeting the mitochondria with elamipretide. Heart Fail Rev 2021;26:237-53. [PMID: 33001359 DOI: 10.1007/s10741-020-10031-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
20 Milane L, Dolare S, Jahan T, Amiji M. Mitochondrial nanomedicine: Subcellular organelle-specific delivery of molecular medicines. Nanomedicine 2021;37:102422. [PMID: 34175455 DOI: 10.1016/j.nano.2021.102422] [Reference Citation Analysis]
21 Bahr T, Welburn K, Donnelly J, Bai Y. Emerging model systems and treatment approaches for Leber's hereditary optic neuropathy: Challenges and opportunities. Biochim Biophys Acta Mol Basis Dis 2020;1866:165743. [PMID: 32105823 DOI: 10.1016/j.bbadis.2020.165743] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
22 Weissman D, Maack C. Redox signaling in heart failure and therapeutic implications. Free Radic Biol Med 2021;171:345-64. [PMID: 34019933 DOI: 10.1016/j.freeradbiomed.2021.05.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Lichscheidt ED, Jespersen NR, Nielsen BRR, Berg K, Seefeldt J, Nyengaard JR, Bøtker HE, Eiskjær H. Abnormal Mitochondrial Function and Morphology in Heart Transplanted Patients with Cardiac Allograft Vasculopathy. The Journal of Heart and Lung Transplantation 2022. [DOI: 10.1016/j.healun.2022.01.1376] [Reference Citation Analysis]
24 Bisaccia G, Ricci F, Gallina S, Di Baldassarre A, Ghinassi B. Mitochondrial Dysfunction and Heart Disease: Critical Appraisal of an Overlooked Association. Int J Mol Sci 2021;22:E614. [PMID: 33435429 DOI: 10.3390/ijms22020614] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Diaz-Vegas A, Sanchez-Aguilera P, Krycer JR, Morales PE, Monsalves-Alvarez M, Cifuentes M, Rothermel BA, Lavandero S. Is Mitochondrial Dysfunction a Common Root of Noncommunicable Chronic Diseases? Endocr Rev 2020;41:bnaa005. [PMID: 32179913 DOI: 10.1210/endrev/bnaa005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 13.0] [Reference Citation Analysis]
26 Gnanaguru G, Mackey A, Choi EY, Arta A, Rossato FA, Gero TW, Urquhart AJ, Scott DA, D'Amore PA, Ng YSE. Discovery of sterically-hindered phenol compounds with potent cytoprotective activities against ox-LDL-induced retinal pigment epithelial cell death as a potential pharmacotherapy. Free Radic Biol Med 2022;178:360-8. [PMID: 34843917 DOI: 10.1016/j.freeradbiomed.2021.11.026] [Reference Citation Analysis]
27 Schwemmlein J, Maack C, Bertero E. Mitochondria as Therapeutic Targets in Heart Failure. Curr Heart Fail Rep 2022. [PMID: 35147851 DOI: 10.1007/s11897-022-00539-0] [Reference Citation Analysis]
28 Mongirdienė A, Skrodenis L, Varoneckaitė L, Mierkytė G, Gerulis J. Reactive Oxygen Species Induced Pathways in Heart Failure Pathogenesis and Potential Therapeutic Strategies. Biomedicines 2022;10:602. [DOI: 10.3390/biomedicines10030602] [Reference Citation Analysis]
29 Allen ME, Pennington ER, Perry JB, Dadoo S, Makrecka-Kuka M, Dambrova M, Moukdar F, Patel HD, Han X, Kidd GK, Benson EK, Raisch TB, Poelzing S, Brown DA, Shaikh SR. The cardiolipin-binding peptide elamipretide mitigates fragmentation of cristae networks following cardiac ischemia reperfusion in rats. Commun Biol 2020;3:389. [PMID: 32680996 DOI: 10.1038/s42003-020-1101-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
30 Butler J, Khan MS, Anker SD, Fonarow GC, Kim RJ, Nodari S, O'Connor CM, Pieske B, Pieske-Kraigher E, Sabbah HN, Senni M, Voors AA, Udelson JE, Carr J, Gheorghiade M, Filippatos G. Effects of Elamipretide on Left Ventricular Function in Patients With Heart Failure With Reduced Ejection Fraction: The PROGRESS-HF Phase 2 Trial. J Card Fail 2020;26:429-37. [PMID: 32068002 DOI: 10.1016/j.cardfail.2020.02.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
31 Garlid AO, Schaffer CT, Kim J, Bhatt H, Guevara-Gonzalez V, Ping P. TAZ encodes tafazzin, a transacylase essential for cardiolipin formation and central to the etiology of Barth syndrome. Gene 2020;726:144148. [PMID: 31647997 DOI: 10.1016/j.gene.2019.144148] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
32 Baybayon-grandgeorge AN, Pietra AE, Miyamoto SD, Garcia AM. Medical Therapies for Heart Failure in Hypoplastic Left Heart Syndrome. JCDD 2022;9:152. [DOI: 10.3390/jcdd9050152] [Reference Citation Analysis]
33 Koňaříková E, Marković A, Korandová Z, Houštěk J, Mráček T. Current progress in the therapeutic options for mitochondrial disorders. Physiol Res 2020;69:967-94. [PMID: 33129249 DOI: 10.33549/physiolres.934529] [Reference Citation Analysis]
34 Silva Pedroza AA, Bernardo EM, Pereira AR, Andrade Silva SC, Lima TA, de Moura Freitas C, da Silva Junior JC, Gomes DA, Ferreira DS, Lagranha CJ. Moderate offspring exercise offsets the harmful effects of maternal protein deprivation on mitochondrial function and oxidative balance by modulating sirtuins. Nutr Metab Cardiovasc Dis 2021;31:1622-34. [PMID: 33810953 DOI: 10.1016/j.numecd.2021.01.006] [Reference Citation Analysis]
35 Sabbah HN. Targeting the Mitochondria in Heart Failure: A Translational Perspective. JACC Basic Transl Sci 2020;5:88-106. [PMID: 32043022 DOI: 10.1016/j.jacbts.2019.07.009] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
36 Lin PH, Duann P. Dyslipidemia in Kidney Disorders: Perspectives on Mitochondria Homeostasis and Therapeutic Opportunities. Front Physiol 2020;11:1050. [PMID: 33013450 DOI: 10.3389/fphys.2020.01050] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
37 Spaczyńska M, Rocha SF, Oliver E. Pharmacology of Pulmonary Arterial Hypertension: An Overview of Current and Emerging Therapies. ACS Pharmacol Transl Sci 2020;3:598-612. [PMID: 32832865 DOI: 10.1021/acsptsci.0c00048] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
38 Azuma K, Ikeda K, Inoue S. Functional Mechanisms of Mitochondrial Respiratory Chain Supercomplex Assembly Factors and Their Involvement in Muscle Quality. Int J Mol Sci 2020;21:E3182. [PMID: 32365950 DOI: 10.3390/ijms21093182] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
39 Muszyński P, Bonda TA. Mitochondrial Dysfunction in Atrial Fibrillation-Mechanisms and Pharmacological Interventions. J Clin Med 2021;10:2385. [PMID: 34071563 DOI: 10.3390/jcm10112385] [Reference Citation Analysis]
40 Szabo TM, Frigy A, Nagy EE. Targeting Mediators of Inflammation in Heart Failure: A Short Synthesis of Experimental and Clinical Results. Int J Mol Sci 2021;22:13053. [PMID: 34884857 DOI: 10.3390/ijms222313053] [Reference Citation Analysis]
41 Njoroge JN, Teerlink JR. Pathophysiology and Therapeutic Approaches to Acute Decompensated Heart Failure. Circ Res 2021;128:1468-86. [PMID: 33983837 DOI: 10.1161/CIRCRESAHA.121.318186] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Garcia AM, McPhaul JC, Sparagna GC, Jeffrey DA, Jonscher R, Patel SS, Sucharov CC, Stauffer BL, Miyamoto SD, Chatfield KC. Alteration of cardiolipin biosynthesis and remodeling in single right ventricle congenital heart disease. Am J Physiol Heart Circ Physiol 2020;318:H787-800. [PMID: 32056460 DOI: 10.1152/ajpheart.00494.2019] [Reference Citation Analysis]
43 Javadov S, Jang S, Chapa-Dubocq XR, Khuchua Z, Camara AK. Mitochondrial respiratory supercomplexes in mammalian cells: structural versus functional role. J Mol Med (Berl) 2021;99:57-73. [PMID: 33201259 DOI: 10.1007/s00109-020-02004-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]